In such a crowded and competitive market, the ability to differentiate your product and ensure the success of your commercial strategy has never been more important.

The oncology market continues to represent the largest and fastest growing therapeutic area within the bio/pharmaceutical industry.  It is therefore critical, that in such a crowded and competitive market, manufacturers of oncology products develop commercial strategies that differentiate their product in the market.  While there are many opportunities in this market, there are also a number of challenges companies face in regards to product planning, sales and marketing, market access, distribution and reimbursement.

This annual forum examines oncology-specific commercial planning for each stage of the product lifecycle and cutting-edge approaches used by the leading manufacturers of oncology products.

In 2010, more than 100 senior-level executives from leading oncology companies, small and large, attended representing: Abbott, Allos Therapeutics, Ascenta Therapeutics, AVEO Pharmaceuticals, Bayer, Celgene, Cephalon, ChemGenex Therapeutics, Daiichi Sankyo, Eisai, Enzon Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, MannKind Corporation, Millennium Pharmaceuticals, The Takeda Oncology Company, Novartis, Pfizer, sanofi-aventis, Spectrum Pharmaceuticals, Wellstat Therapeutics and many more!

Topics being researched for 2011 include:

• Strategic overview of the oncology market
• Update on the top regulatory issues surrounding oncologics
• Impact of healthcare reform and comparative effectiveness research on oncology commercialization
• Evolving pricing, reimbursement and access environment for oncology products
• Launch strategies for oral oncologics

• Sales and marketing strategies for hospital and clinic targeting

Plus! An Interactive Payor Panel Discussion

Hear what some of our previous attendees had to say:

“Overall very useful content and good networking opportunities.”
– 2010 Attendee, Laura Strong, President and COO, Quintessence

“Like many meetings, great forum for networking and discussion.  But, in this particular case, this is truly a win-win approach where both the speakers and audience learned a lot.”
– 2009 Attendee, Pierre Dodoin, M.D., Senior Vice President and Chief Medical Officer, ARIAD Pharmaceuticals

“I appreciate the focus on market research and data. This is atypical in this type of conference and is appreciated.”
– 2009 Attendee, Jocelyn Gilmour, Senior Manager, Endo Pharmaceuticals

“One of the best conferences of this type I have attended.  Intelligently organized and coordinated, knowledgeable, “real-world” speakers, few mere ‘infomercials.’”
– 2009 Attendee, Michael Bamat, Senior Vice President R&D, Wellstat Therapeutics Corporation

“Oncologics and the evolving market is a highly complex and constantly changing environment. These two days help considerably in covering some of the very issues we face in developing robust commercial strategies.”
– 2009 Attendee, Andrew Moody, Senior Vice President, IDIS Pharmaceuticals

Sponsors/Exhibitors:

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.